Skip to main content
. Author manuscript; available in PMC: 2014 May 29.
Published in final edited form as: ALTEX. 2011;28(3):236–241. doi: 10.14573/altex.2011.3.236

Fig. 1. Schematic diagram incorporating concepts for preliminary assessment of nanomaterial bioactivity.

Fig. 1

Some existing tests – such as genetic toxicity protocols – must be evaluated and validated for their suitability in testing nanomaterials.